Rilpivirine/tenofovir/emtricitabine

rilpivirine/tenofovir disoproxil fumarate/emtricitabine · Janssen Pharmaceuticals K.K.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Rilpivirine/tenofovir/emtricitabine, covering 2017-01-02 to 2017-01-02. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Pharmacokinetics of Rilpivirine/Tenofovir/Emtricitabine After a Single-Oral Administration in Healthy Japanese Adult Male Participants [Phase 4]

See pricing